The subcellular localization and activity of cortactin is regulated by acetylation and interaction with Keap1

Science Signaling

Volumn 8, Issue 404, 2015, Pages

  Ito, Akihiro ^a,b   Shimazu, Tadahiro ^a   Maeda, Satoko ^b   Shah, Asad Ali ^a,c   Tsunoda, T ^d,e   Iemura, Shun Ichiro ^f   Natsume, Toru ^f   Suzuki, Takafumi ^g   Motohashi, Hozumi ^g   Yamamoto, Masayuki ^g   Yoshida, Minoru ^a,b,c,e  

^a RIKEN   (Japan)

^b Elements Chemistry Laboratory   (Japan)

^c SAITAMA UNIVERSITY   (Japan)

^d Institute of Physical and Chemical Research   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^f NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^g TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTACTIN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; CTTN PROTEIN, HUMAN; CTTN PROTEIN, MOUSE; CYTOSKELETON PROTEIN; KEAP1 PROTEIN, HUMAN; KEAP1 PROTEIN, MOUSE; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; EMBRYO; HUMAN; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; ACETYLATION; ANIMAL; CELL CULTURE; CELL MOTION; CYTOSOL; GENETICS; KNOCKOUT MOUSE; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; PROTEIN TRANSPORT;

ACETYLATION; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL MOVEMENT; CELLS, CULTURED; CORTACTIN; CYTOSKELETAL PROTEINS; CYTOSOL; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; OXIDATIVE STRESS; PROTEIN TRANSPORT;

EID: 84954488890     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.aad0667     Document Type: Article

References (49)

1. K. Taguchi, H. Motohashi, M. Yamamoto, Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16, 123-140 (2011).
2. H. Motohashi, M. Yamamoto, Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 10, 549-557 (2004).
3. R. J. Daly, Cortactin signalling and dynamic actin networks. Biochem. J. 382, 13-25 (2004).
4. B. L. Lua, B. C. Low, Cortactin phosphorylation as a switch for actin cytoskeletal network and cell dynamics control. FEBS Lett. 579, 577-585 (2005).
5. M. Selbach, S. Backert, Cortactin: An Achilles' heel of the actin cytoskeleton targeted by pathogens. Trends Microbiol. 13, 181-189 (2005).
6. S. A. Weed, J. T. Parsons, Cortactin: Coupling membrane dynamics to cortical actin assembly. Oncogene 20, 6418-6434 (2001).
7. L. Buday, J. Downward, Roles of cortactin in tumor pathogenesis. Biochim. Biophys. Acta 1775, 263-273 (2007).
8. A. M. Weaver, Cortactin in tumor invasiveness. Cancer Lett. 265, 157-166 (2008).
9. J. A. Åkervall Y. Jin, J. P.Wennerberg, U. K. Zatterström, E. Kjellén, F. Mertens, R. Willén, N. Mandahl, S. Heim, F. Mitelman, Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer 76, 853-859 (1995).
10. X.-Z. Xu, M. V. Garcia, T.-Y. Li, L.-Y. Khor, R. S. Gajapathy, C. Spittle, S. Weed, S. R. Lessin, H. Wu, Cytoskeleton alterations in melanoma: Aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression. Mod. Pathol. 23, 187-196 (2010).
11. H. Hirakawa, K. Shibata, T. Nakayama, Localization of cortactin is associated with colorectal cancer development. Int. J. Oncol. 35, 1271-1276 (2009).
12. S. A. Weed, A. V. Karginov, D. A. Schafer, A. M. Weaver, A. W. Kinley, J. A. Cooper, J. T. Parsons, Cortactin localization to sites of actin assembly in lamellipodia requires interactions with F-actin and the Arp2/3 complex. J. Cell Biol. 151, 29-40 (2000).
13. H. Wu, J. T. Parsons, Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J. Cell Biol. 120, 1417-1426 (1993).
14. K. C. Kirkbride, B. H. Sung, S. Sinha, A. M. Weaver, Cortactin: A multifunctional regulator of cellular invasiveness. Cell Adh. Migr. 5, 187-198 (2011).
15. X. Zhang, Z. Yuan, Y. Zhang, S. Yong, A. Salas-Burgos, J. Koomen, N. Olashaw, J. T. Parsons, X.-J. Yang, S. R. Dent, T.-P. Yao, W. S. Lan, E. Seto, HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol. Cell 27, 197-213 (2007).
16. S. J. Haggarty, K. M. Koeller, J. C. Wong, C. M. Grozinger, S. L. Schreiber, Domainselective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc. Natl. Acad. Sci. U.S.A. 100, 4389-4394 (2003).
17. Y. Zhang, M. Zhang, H. Dong, S. Yong, X. Li, N. Olashaw, P. A. Kruk, J. Q. Cheng, W. Bai, J. Chen, S. V. Nicosia, X. Zhang, Deacetylation of cortactin by SIRT1 promotes cell migration. Oncogene 28, 445-460 (2009).
18. K. Nakane, Y. Fujita, R. Terazawa, Y. Atsumi, T. Kato, Y. Nozawa, T. Deguchi, M. Ito, Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells. Int. J. Urol. 19, 71-79 (2012).
19. Q. Zuo, W. Wu, X. Li, L. Zhao, W. Chen, HDAC6 and SIRT2 promote bladder cancer cell migration and invasion by targeting cortactin. Oncol. Rep. 27, 819-824 (2012).
20. D. Kaluza, J. Kroll, S. Gesierich, T.-P. Yao, R. A. Boon, E. Hergenreider, M. Tjwa, L. Rössig, E. Seto, H. G. Augustin, A. M. Zeiher, S. Dimmele, C. Urbich, Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin. EMBO J. 30, 4142-4156 (2011).
21. R. Hao, P. Nanduri, Y. Rao, R. S. Panichelli, A. Ito, M. Yoshida, T.-P. Yao, Proteasomes activate aggresome disassembly and clearance by producing unanchored ubiquitin chains. Mol. Cell 51, 819-828 (2013).
22. M. Yoshida, M. Kijima, M. Akita, T. Beppu, Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265, 17174-17179 (1990).
23. A. Ito, C.-H. Lai, X. Zhao, S. Saito, M. H. Hamilton, E. Appella, T.-P. Yao, p300/CBPmediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J. 20, 1331-1340 (2001).
24. M. Fornerod, M. Ohno, M. Yoshida, I. W. Mattaj, CRM1 is an export receptor for leucinerich nuclear export signals. Cell 90, 1051-1060 (1997).
25. N. Kudo, B. Wolff, T. Sekimoto, E. P. Schreiner, Y. Yoneda, M. Yanagida, S. Horinouchi, M. Yoshida, Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 242, 540-547 (1998).
26. K. Itoh, J. Mimura, M. Yamamoto, Discovery of the negative regulator of Nrf2, Keap1: A historical overview. Antioxid. Redox Signal. 13, 1665-1678 (2010).
27. M. Komatsu, H. Kurokawa, S. Waguri, K. Taguchi, A. Kobayashi, Y. Ichimura, Y.-S. Sou, I. Ueno, A. Sakamoto, K. I. Tong, M. Kim, Y. Nishito, S.-i. Iemura, T. Natsume, T. Ueno, E. Kominami, H. Motohashi, K. Tanaka, M. Yamamoto, The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat. Cell Biol. 12, 213-223 (2010).
28. M.-I. Kang, A. Kobayashi, N. Wakabayashi, S.-G. Kim, M. Yamamoto, Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc. Natl. Acad. Sci. U.S.A. 101, 2046-2051 (2004).
29. B. Padmanabhan, M. Scharlock, K. I. Tong, Y. Nakamura, M.-I. Kang, A. Kobayashi, T. Matsumoto, A. Tanaka, M. Yamamoto, S. Yokoyama, Purification, crystallization and preliminary X-ray diffraction analysis of the Kelch-like motif region of mouse Keap1. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 61, 153-155 (2005).
30. A. G. S. H. van Rossum, W. H. Moolenaar, E. Schuuring, Cortactin affects cell migration by regulating intercellular adhesion and cell spreading. Exp. Cell Res. 312, 1658-1670 (2006).
31. M.-L. Wang, C.-M. Pan, S.-H. Chiou, W.-H. Chen, H.-Y. Chang, O. K.-S. Lee, H.-S. Hsu, C.-W. Wu, Oncostatin M modulates the mesenchymal-epithelial transition of lung adenocarcinoma cells by a mesenchymal stem cell-mediated paracrine effect. Cancer Res. 72, 6051-6064 (2012).
32. S. A. Weed, Y. Du, J. T. Parsons, Translocation of cortactin to the cell periphery is mediated by the small GTPase Rac1. J. Cell Sci. 111, 2433-2443 (1998).
33. E. W. Krueger, J. D. Orth, H. Cao, M. A. McNiven, A dynamin-cortactin-Arp2/3 complex mediates actin reorganization in growth factor-stimulated cells. Mol. Biol. Cell 14, 1085-1096 (2003).
34. G. Rachakonda, K. R. Sekhar, D. Jowhar, P. C. Samson, J. P. Wikswo, R. D. Beauchamp, P. K. Datta, M. L. Freeman, Increased cell migration and plasticity in Nrf2-deficient cancer cell lines. Oncogene 29, 3703-3714 (2010).
35. T. Ashino, M. Yamamoto, T. Yoshida, S. Numazawa, Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia. Arterioscler. Thromb. Vasc. Biol. 33, 760-768 (2013).
36. T. Ohta, K. Iijima, M. Miyamoto, I. Nakahara, H. Tanaka, M. Ohtsuji, T. Suzuki, A. Kobayashi, J. Yokota, T. Sakiyama, T. Shibata, M. Yamamoto, S. Hirohashi, Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res. 68, 1303-1309 (2008).
37. A. Singh, V. Misra, R. K. Thimmulappa, H. Lee, S. Ames, M. O. Hoque, J. G. Herman, S. B. Baylin, D. Sidransky, E. Gabrielson, M. V. Brock, S. Biswal, Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLOS Med. 3, e420 (2006).
38. B. Padmanabhan, K. I. Tong, T. Ohta, Y. Nakamura, M. Scharlock, M. Ohtsuji, M.-I. Kang, A. Kobayashi, S. Yokoyama, M. Yamamoto, Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol. Cell 21, 689-700 (2006).
39. H. Khan, R. C. Killoran, A. Brickenden, J. Fan, D. Yang, W.-Y. Choy, Molecular effects of cancer-associated somatic mutations on the structural and target recognition properties of Keap1. Biochem. J. 467, 141-151 (2015).
40. C. M. Mahaffey, H. Zhang, A. Rinna, W. Holland, P. C. Mack, H. J. Forman, Multidrugresistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma. Free Radic. Biol. Med. 46, 1650-1657 (2009).
41. T. Suzuki, J. Maher, M. Yamamoto, Select heterozygous Keap1 mutations have a dominant-negative effect on wild-type Keap1 in vivo. Cancer Res. 71, 1700-1709 (2011).
42. F. Xue, L. Cooley, kelch encodes a component of intercellular bridges in Drosophila egg chambers. Cell 72, 681-693 (1993).
43. M. Velichkova, T. Hasson, Keap1 in adhesion complexes. Cell Motil. Cytoskeleton 56, 109-119 (2003).
44. L. M. Zipper, R. T. Mulcahy, The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm. J. Biol. Chem. 277, 36544-36552 (2002).
45. A. Shvetsov, E. Berkane, D. Chereau, R. Dominguez, E. Reisler, The actin-binding domain of cortactin is dynamic and unstructured and affects lateral and longitudinal contacts in F-actin. Cell Motil. Cytoskeleton 66, 90-98 (2009).
46. K. Nishi, M. Yoshida, M. Nishimura, M. Nishikaw, M. Nishiyama, S. Horinouchi, T. Beppu, A leptomycin B resistance gene of Schizosaccharomyces pombe encodes a protein similar to the mammalian P-glycoproteins. Mol. Microbiol. 6, 761-769 (1992).
47. N. Wakabayashi, K. Itoh, J. Wakabayashi, H. Motohashi, S. Noda, S. Takahashi, S. Imakado, T. Kotsuji, F. Otsuka, D. R. Roop, T. Harada, J. D. Engel, M. Yamamoto, Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat. Genet. 35, 238-245 (2003).
48. A. Matsuyama, T. Shimazu, Y. Sumida, A. Saito, Y. Yoshimatsu, D. Seigneurin-Berny, H. Osada, Y. Komatsu, N. Nishino, S. Khochbin, S. Horinouchi, M. Yoshida, In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. EMBO J. 21, 6820-6831 (2002).
49. T. Shimazu, Y. Komatsu, K. I. Nakayama, H. Fukazawa, S. Horinouchi, M. Yoshida, Regulation of SV40 large T-antigen stability by reversible acetylation. Oncogene 25, 7391-7400 (2006).